Table 3.

Weight gain in adults starting antiretroviral therapy and alive on therapy six months later, disaggregated by gender and Ssage of disease

	Male	Female
Patients in Stage 1&2 (N = 78)	27	51
Mean Baseline weight in kg	58.8	52.0
Mean cumulative weight gain in kg (%) at 1 month	+1.5(2.6%)	+0.9(1.8%)
Mean cumulative weight gain in kg (%) at 3 months	+2.5(4.4%)	+2.3(4.5%)
Mean cumulative weight gain in kg (%) at 6 months	+4.5(7.85%)	+3.3(6.7%)
Patients in Stage 3 (N = 369)	113	256
Mean Baseline weight in kg	52.5	47.5
Mean cumulative weight gain in kg (%) at 1 month	+1.5(3%)	+1.1(2.4%)
Mean cumulative weight gain in kg (%) at 3 months	+3.2(6.4%)	+2.3(5.2%)
Mean cumulative weight gain in kg (%) at 6 months	+6.2(12.3%)	+5.0(11.2%)
Patients in Stage 4 (N = 182)	73	109
Mean Baseline weight in kg	54.1	45.3
Mean cumulative weight gain in kg (%) at 1 month	+1.7(3.4%)	+1.0(2.3%)
Mean cumulative weight gain in kg (%) at 3 months	+2.9(5.6%)	+2.9(6.9%)
Mean cumulative weight gain in kg (%) at 6 months	+6.2(12.3%)	+6.1(14.7%)

Legend: Standard deviations are not shown in the Table -comparisons between different groups within each gender category carried out using student's t test - the only significant difference is at 6 months between women in Stage 1&2 compared with women in Stage 4 (p<0.05)